–
Theriva Biologics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.3
FY22:
−21.6
FY23:
−21.4
FY24:
−26.3
FY25:
−24.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.2
FY22:
−21.5
FY23:
−21.3
FY24:
–
FY25:
−24.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.3
FY22:
−21.1
FY23:
−20.0
FY24:
−25.7
FY25:
−23.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.3
FY22:
−19.7
FY23:
−18.3
FY24:
−25.7
FY25:
−23.7
All amounts in millions USD